The ZDHHC18 expression level was increased in perinecrotic and microvascular proliferative regions, and that of ZDHHC23 was associated with the leading edge and infiltrating tumor regions in GBM (Fig. 2a). Here, ZDHHC23 is linked to neoplasm.